U.S. markets close in 4 hours 53 minutes

FSD Pharma Inc. (HUGE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.63000.0000 (0.00%)
As of 11:02AM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 7/26/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 7

Trading Information

Stock Price History

Beta (5Y Monthly) 1.09
52-Week Change 3-56.42%
S&P500 52-Week Change 335.08%
52 Week High 36.8700
52 Week Low 31.2800
50-Day Moving Average 31.7311
200-Day Moving Average 31.9242

Share Statistics

Avg Vol (3 month) 3438.68k
Avg Vol (10 day) 3267.11k
Shares Outstanding 535.99M
Implied Shares Outstanding 635.99M
Float 33.97M
% Held by Insiders 113.54%
% Held by Institutions 12.93%
Shares Short (Jul 14, 2021) 4695.44k
Short Ratio (Jul 14, 2021) 42.84
Short % of Float (Jul 14, 2021) 4N/A
Short % of Shares Outstanding (Jul 14, 2021) 41.93%
Shares Short (prior month Jun 14, 2021) 4759.53k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Oct 15, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:201
Last Split Date 3Oct 15, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-37.04%
Return on Equity (ttm)-60.26%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -29.18M
Net Income Avi to Common (ttm)-29.7M
Diluted EPS (ttm)-1.9360
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)49.84M
Total Cash Per Share (mrq)1.38
Total Debt (mrq)476.74k
Total Debt/Equity (mrq)0.70
Current Ratio (mrq)7.73
Book Value Per Share (mrq)1.90

Cash Flow Statement

Operating Cash Flow (ttm)-19.12M
Levered Free Cash Flow (ttm)-2.78M